Benztropine FDA Link Generic

A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.

Also Known As:

Benzatropine; Cogentin; Apo-Benztropine; Bensylate; Benzatropine Mesylate; Benzatropine Methanesulfonate; Benzatropine Methanesulfonate, Hydrobromide; Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer; Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer; Benztropine Mesylate; Cogentinol; N-Methylbenztropine; PMS-Benztropine; Apo Benztropine; Hydrobromide Benzatropine Methanesulfonate; Mesylate, Benzatropine; Mesylate, Benztropine; Methanesulfonate, Benzatropine; Methanesulfonate, Hydrobromide Benzatropine; N Methylbenztropine; PMS Benztropine; 8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-

Pharmalogical Action Categories:

Antiparkinson Agents
Dopamine Uptake Inhibitors
Muscarinic Antagonists
Parasympatholytics

Organic Chemicals: 133
- Aza Compounds: 3
  - Azabicyclo Compounds
    - Tropanes: 1
      - Benztropine: 210
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Tropanes: 1
    - Benztropine: 210
- Bridged-Ring Heterocyclic Compounds
  - Tropanes: 1
    - Benztropine: 210
  - Heterocyclic Bridged Bicyclo Compounds
    - Azabicyclo Compounds
      - Tropanes: 1
        Benztropine: 210

4'-chloro-3-(diphenylmethoxy)tropane

Bio-Agent Context: Research Results